Research graph
References from Selective elimination of quiescent cancer cells by dequalinium chloride via ROS ‐mediated ferroptosis. Local targets link to admitted publications; unresolved targets remain external evidence.
Mechanisms of disseminated cancer cell dormancy: an awakening field
10.1038/nrc3793 · 2014 · External reference
Models, mechanisms and clinical evidence for cancer dormancy
10.1038/nrc2256 · 2007 · External reference
Targeting cancer cell dormancy
10.1016/j.tips.2018.12.004 · 2019 · External reference
Cellular dormancy in minimal residual disease following targeted therapy
10.1186/s13058-021-01416-9 · 2021 · External reference
The current paradigm and challenges ahead for the dormancy of disseminated tumor cells
2020 · External reference
Dormancy in cancer
10.1111/cas.13917 · 2019 · External reference
The dormant cancer cell life cycle
10.1038/s41568-020-0263-0 · 2020 · External reference
The force awakens: metastatic dormant cancer cells
10.1038/s12276-020-0423-z · 2020 · External reference
The role of cancer cell bioenergetics in dormancy and drug resistance
10.1007/s10555-023-10081-7 · 2023 · External reference
Metabolic landscape of disseminated cancer dormancy
10.1016/j.trecan.2024.10.005 · 2025 · External reference
AGE/RAGE axis regulates reversible transition to quiescent states of ALK‐rearranged NSCLC and pancreatic cancer cells in monolayer cultures
10.1038/s41598-022-14272-0 · 2022 · External reference
ROS generation and antioxidant defense Systems in Normal and Malignant Cells
10.1155/2019/6175804 · 2019 · External reference
How mitochondria produce reactive oxygen species
10.1042/bj20081386 · 2009 · External reference
Activation of apoptosis signalling pathways by reactive oxygen species
10.1016/j.bbamcr.2016.09.012 · 2016 · External reference
Mitochondrial control of cell death
10.1038/74994 · 2000 · External reference
Reactive oxygen species, cellular redox systems, and apoptosis
10.1016/j.freeradbiomed.2009.12.022 · 2010 · External reference
Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease
10.1016/j.cell.2017.09.021 · 2017 · External reference
Tumor dormancy and interplay with hypoxic tumor microenvironment
10.3390/ijms20174305 · 2019 · External reference
Visualization of endogenous p27 and Ki67 reveals the importance of a c‐Myc‐driven metabolic switch in promoting survival of quiescent cancer cells
10.7150/thno.63763 · 2021 · External reference
Metabolic features of tumor dormancy: possible therapeutic strategies
2022 · External reference
Modulation of oxidative stress as an anticancer strategy
10.1038/nrd4002 · 2013 · External reference
Ferroptosis in cancer therapy: a novel approach to reversing drug resistance
10.1186/s12943-022-01530-y · 2022 · External reference
Ferroptosis in cancer: revealing the multifaceted functions of mitochondria
10.1007/s00018-025-05812-8 · 2025 · External reference
Ferroptosis: molecular mechanisms and health implications
10.1038/s41422-020-00441-1 · 2021 · External reference
Use of locally delivered dequalinium chloride in the treatment of vaginal infections: a review
10.1007/s00404-015-3914-8 · 2016 · External reference
Medicinal applications and molecular targets of dequalinium chloride
10.1016/j.bcp.2021.114467 · 2021 · External reference
Dequalinium, a topical antimicrobial agent, displays anticarcinoma activity based on selective mitochondrial accumulation
10.1073/pnas.84.15.5444 · 1987 · External reference
Effects of the antitumoural dequalinium on NB4 and K562 human leukemia cell lines
10.1016/j.leukres.2005.03.014 · 2005 · External reference
Dequalinium induces cell death in human leukemia cells by early mitochondrial alterations which enhance ROS production
10.1016/j.leukres.2006.11.018 · 2007 · External reference
Dequalinium induces human leukemia cell death by affecting the redox balance
10.1016/j.leukres.2011.03.012 · 2011 · External reference
Characterization of dequalinium as a XIAP antagonist that targets the BIR2 domain
10.1007/s10495-011-0582-4 · 2011 · External reference
Changes in mitochondrial function induced by dequalinium precede oxidative stress and apoptosis in the human prostate‐cancer cell line PC‐3
10.1134/s0026893314030133 · 2014 · External reference
Dormancy of cancer cells with suppression of AKT activity contributes to survival in chronic hypoxia
10.1371/journal.pone.0098858 · 2014 · External reference
Fiji: an open‐source platform for biological‐image analysis
10.1038/nmeth.2019 · 2012 · External reference
Ferroptosis: an iron‐dependent form of nonapoptotic cell death
10.1016/j.cell.2012.03.042 · 2012 · External reference
Induction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments
10.1038/ncomms4295 · 2014 · External reference
The iron chelator and OXPHOS inhibitor VLX600 induces mitophagy and an autophagy‐dependent type of cell death in glioblastoma cells
2023 · External reference
Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production
10.1074/jbc.m210432200 · 2003 · External reference
Mitochondria and cell death: outer membrane permeabilization and beyond
10.1038/nrm2952 · 2010 · External reference
Mitochondrial reactive oxygen species (ROS) and ROS‐induced ROS release
10.1152/physrev.00026.2013 · 2014 · External reference
Regulation of Ferroptotic cancer cell death by GPX4
10.1016/j.cell.2013.12.010 · 2014 · External reference
Dependency of a therapy‐resistant state of cancer cells on a lipid peroxidase pathway
10.1038/nature23007 · 2017 · External reference
A cell state‐specific metabolic vulnerability to GPX4‐dependent ferroptosis in glioblastoma
10.1038/s44318-024-00176-4 · 2024 · External reference
Drug‐tolerant persister cancer cells are vulnerable to GPX4 inhibition
10.1038/nature24297 · 2017 · External reference
